0001253497-25-000010.txt : 20251210 0001253497-25-000010.hdr.sgml : 20251210 20251210170009 ACCESSION NUMBER: 0001253497-25-000010 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20251207 FILED AS OF DATE: 20251210 DATE AS OF CHANGE: 20251210 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: GLENN JOHN CENTRAL INDEX KEY: 0001253497 ORGANIZATION NAME: FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-36534 FILM NUMBER: 251562619 MAIL ADDRESS: STREET 1: C/O IRADIMED CORPORATION STREET 2: 12705 INGENUITY DRIVE CITY: ORLANDO STATE: FL ZIP: 32826 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: IRADIMED CORP CENTRAL INDEX KEY: 0001325618 STANDARD INDUSTRIAL CLASSIFICATION: SURGICAL & MEDICAL INSTRUMENTS & APPARATUS [3841] ORGANIZATION NAME: 08 Industrial Applications and Services EIN: 731408526 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 12705 INGENUITY DRIVE CITY: ORLANDO STATE: FL ZIP: 32826 BUSINESS PHONE: 4076778022 MAIL ADDRESS: STREET 1: 12705 INGENUITY DRIVE CITY: ORLANDO STATE: FL ZIP: 32826 4 1 form4-12102025_051204.xml X0508 4 2025-12-07 0001325618 IRADIMED CORP IRMD 0001253497 GLENN JOHN C/O IRADIMED CORPORATION 12705 INGENUITY DRIVE ORLANDO FL 32826 false true false false CHIEF FINANCIAL OFFICER 0 Common Stock 2025-12-07 4 M 0 10504 A 13004 D Common Stock 2025-12-07 4 F 0 3383 94.57 D 9621 D Common Stock 2025-12-07 4 M 0 21008 A 30629 D Common Stock 2025-12-07 4 F 0 8267 94.57 D 22362 D Restricted Stock Units 2025-12-07 4 M 0 10504 0 D Common Stock 10504 0 D Performance-based Restricted Stock Units 2025-12-07 4 M 0 21008 0 D Common Stock 21008 0 D Restricted stock units convert into common stock on a one-for-one basis. If the relative measure at December 7, 2025 and for the three-year period then ended is: (i) less than or equal to 80% of the peer group, no vesting would occur, (ii) between 80% and 100% of the peer group, the number of shares vesting would be pro-rata against the nominal granted shares, (iii) equal to 100% of the peer group, the number of shares vesting would be the nominal granted shares, (iv) between 100%and 120% of the peer group, the number of shares vesting would be pro-rata against an additional tranche of the nominal granted shares plus the nominal granted shares, and (v) if 120% or greater of the peer group, the number of shares vesting would be double the nominal granted shares. The reporting person received restricted stock units ("RSUs") under Iradimed Corporation's 2014 Equity Incentive Plan. The RSUs vest in full on the third anniversary of the grant date, December 7, 2025. Upon vesting, the reporting person will receive a number of shares of common stock equal to the number of RSUs that have vested. On December 7, 2022, the reporting person received performance-based restricted stock units ("PRSUs") under Iradimed Corporation's 2014 Equity Incentive Plan. Vesting of these PRSUs depends on the reporting person's achievement of specified relative ranking of total shareholder return over a three-year period from December 8, 2022 through December 7, 2025. /s/ John Glenn 2025-12-10